207 related articles for article (PubMed ID: 35439359)
1. Characterization of KIR
Meazza R; Falco M; Canevali P; Loiacono F; Colomar-Carando N; Muntasell A; Rea A; Mingari MC; Locatelli F; Moretta L; Lopez-Botet M; Pende D
HLA; 2022 Aug; 100(2):119-132. PubMed ID: 35439359
[TBL] [Abstract][Full Text] [Related]
2. Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes.
Falco M; Meazza R; Alicata C; Canevali P; Muntasell A; Bottino C; Moretta L; Pende D; Lopez-Botet M
HLA; 2022 Aug; 100(2):107-118. PubMed ID: 35411634
[TBL] [Abstract][Full Text] [Related]
3. Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance.
Le Luduec JB; Boudreau JE; Freiberg JC; Hsu KC
Front Immunol; 2019; 10():734. PubMed ID: 31024561
[TBL] [Abstract][Full Text] [Related]
4. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
5. Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
David G; Morvan M; Gagne K; Kerdudou N; Willem C; Devys A; Bonneville M; Folléa G; Bignon JD; Retière C
Immunology; 2009 Oct; 128(2):172-84. PubMed ID: 19740374
[TBL] [Abstract][Full Text] [Related]
6. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
[TBL] [Abstract][Full Text] [Related]
7. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
9. KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans.
Blokhuis JH; Hilton HG; Guethlein LA; Norman PJ; Nemat-Gorgani N; Nakimuli A; Chazara O; Moffett A; Parham P
Immun Inflamm Dis; 2017 Dec; 5(4):461-468. PubMed ID: 28685972
[TBL] [Abstract][Full Text] [Related]
10. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
[TBL] [Abstract][Full Text] [Related]
11. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
[TBL] [Abstract][Full Text] [Related]
12. KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells.
Sim MJ; Stowell J; Sergeant R; Altmann DM; Long EO; Boyton RJ
Eur J Immunol; 2016 Jan; 46(1):185-91. PubMed ID: 26467237
[TBL] [Abstract][Full Text] [Related]
13. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
Gooneratne SL; Center RJ; Kent SJ; Parsons MS
Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
[TBL] [Abstract][Full Text] [Related]
14. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
[TBL] [Abstract][Full Text] [Related]
15. Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2
Nemat-Gorgani N; Hilton HG; Henn BM; Lin M; Gignoux CR; Myrick JW; Werely CJ; Granka JM; Möller M; Hoal EG; Yawata M; Yawata N; Boelen L; Asquith B; Parham P; Norman PJ
J Immunol; 2018 Apr; 200(8):2640-2655. PubMed ID: 29549179
[TBL] [Abstract][Full Text] [Related]
16. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.
Morvan M; David G; Sébille V; Perrin A; Gagne K; Willem C; Kerdudou N; Denis L; Clémenceau B; Folléa G; Bignon JD; Retière C
Eur J Immunol; 2008 Dec; 38(12):3474-86. PubMed ID: 19016529
[TBL] [Abstract][Full Text] [Related]
17. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells.
Cognet C; Farnarier C; Gauthier L; Frassati C; André P; Magérus-Chatinet A; Anfossi N; Rieux-Laucat F; Vivier E; Schleinitz N
Clin Immunol; 2010 Apr; 135(1):26-32. PubMed ID: 20093094
[TBL] [Abstract][Full Text] [Related]
18. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
Pende D; Marcenaro S; Falco M; Martini S; Bernardo ME; Montagna D; Romeo E; Cognet C; Martinetti M; Maccario R; Mingari MC; Vivier E; Moretta L; Locatelli F; Moretta A
Blood; 2009 Mar; 113(13):3119-29. PubMed ID: 18945967
[TBL] [Abstract][Full Text] [Related]
19. [The characteristics of frequency distribution of KIR2DL1 alleles polymorphism and recognition HLA-C ligand in the Chinese Han population].
Wang M; He J; Bao XJ; Qiu QC; Li Y; Xu C; Yuan XN; Li LJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1038-43. PubMed ID: 24369161
[TBL] [Abstract][Full Text] [Related]
20. Centromeric KIR AA Individuals Harbor Particular KIR Alleles Conferring Beneficial NK Cell Features with Implications in Haplo-Identical Hematopoietic Stem Cell Transplantation.
Dubreuil L; Maniangou B; Chevallier P; Quéméner A; Legrand N; Béné MC; Willem C; David G; Alizadeh M; Makanga DR; Cesbron A; Gendzekhadze K; Gagne K; Retière C
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33271841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]